Aurinia Pharmaceuticals (AUPH) Amortizatization of Intangibles (2022 - 2026)

Aurinia Pharmaceuticals' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• Quarterly Amortizatization of Intangibles fell 12.69% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (down 19.2% YoY) and the FY2025 annual result came in at $10.2 million, down 20.05% from the prior year.
• Amortizatization of Intangibles was $2.3 million for Q1 2026 at Aurinia Pharmaceuticals, down from $2.3 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $3.4 million in Q3 2024 and bottomed at -$211000.0 in Q2 2022.
• A 5-year average of $2.3 million and a median of $2.6 million in 2025 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles surged 1965.0% — and 2025, when it decreased 23.27%.
• Aurinia Pharmaceuticals' Amortizatization of Intangibles stood at $1.6 million in 2022, then surged by 112.13% to $3.3 million in 2023, then decreased by 9.86% to $3.0 million in 2024, then declined by 21.62% to $2.3 million in 2025, then dropped by 0.69% to $2.3 million in 2026.
• Business Quant data shows AUPH's Amortizatization of Intangibles at $2.3 million in Q1 2026, $2.3 million in Q4 2025, and $2.6 million in Q3 2025.